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Abstract
Cancer stem cells are controlled by developmental networks that are often topo-
logically indistinguishable from normal, healthy stem cells. The question is why
cancer stem cells can be both phenotypically distinct and have morphological ef-
fects so different from normal stem cells. The difference between cancer stem cells
and normal stem cells lies not in differences their network architecture, but rather
in the spatial-temporal locality of their activation in the genome and the resulting
expression in the body. The metastatic potential cancer stem cells is not based
primarily on their network divergence from normal stem cells, but on non-network
based genetic changes that enable the evolution of gene-based phenotypic proper-
ties of the cell that permit its escape and travel to other parts of the body. Stem cell
network theory allows the precise prediction of stem cell behavioral dynamics and
a mathematical description of stem cell proliferation for both normal and cancer
stem cells. It indicates that the best therapeutic approach is to tackle the highest
order stem cells first, otherwise spontaneous remission of so called cured cancers
will always be a danger. Stem cell networks point to a pathway to new methods to
diagnose and cure not only stem cell cancers but cancers generally.
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1 Introduction
How do healthy and cancer stem cells differ? In my stem cell networks paper [33] there is
considerable overlap with my cancer networks paper [30]. The reason is that cancer stem cell
networks and healthy stem cell networks are in many ways topologically indistinguishable.
Yet, the phenotype of a cancer stem cell and the cells it generates may differ greatly from
healthy stem cells even if they are governed by equivalent network types.
One reason for the difference is if the spatial-temporal activation or locality of cancer stem cell
networks within the global network that controls the development of the organism is abnormal.
If a stem cell network is inappropriately expressed in the global developmental control network
it can result in very different cell phenotype as well as an abnormal locus of tumor growth. So
too, if a stem cell network is inappropriately activated in any cell, then abnormal tumor like
growth may result in that location of the body.
2 Cancer stem cell formation
A linear, 1st-order stem cell can form anywhere in a given developmental control network when
a single loop is formed that generates two daughter cells, one that whose downstream offspring
loops back to the original stem cell and one that goes down another pathway that does not
loop back. The phenotype of the resulting tumor depends on the location of the initiation
point of the loop, the loop pathway and the pathway of the non-looping terminal network.
For example, A divides into two daughter cells B and C where B is controlled by network NB
and C is controlled by network NC and where NB loops back to A eventually. And NC is a
terminal developmental network. The simplest case is where the networks consist of just one
node, e.g., NB = A and NC = T where T is some terminal cell state. The cell at node A then
just generates terminal cells of type T and loops back to itself. But if NB and/or NC are more
complex networks then one can get very odd stem cell cancers. If then a second mutational
transformation results in yet a second loop back to A in NC the second daughter cell’s network,
we suddenly get exponential, explosive cell proliferation (assuming no conditional activation
such as dependence on cell-cell signaling).
3 Activation potential
Activation of a hidden stem cell network is necessary for stem cell development or cancer
development to initiate. Once initiated it continues ad infinitum unless held in check by some
necessary condition such as a cell signal or other source. Thus there may exist many passive
stem cell and exponential networks in the genome but that are inactive and not accessible in the
normal execution of the global developmental control network. Environmental influences can
lead to the activation of such passive networks resulting in tumors whose properties depend on
the location and topology of the network. Further mutations in such an activated network can
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have severe consequences by changing a linear stem cell network into an exponential network
[33, 30] as illustrated in Figure 1 below.
4 A potential danger with all stem cells
Thus, even healthy normal stem cells carry with them an inherent danger. The reason is that
mutations that transform developmental networks can convert a normal, healthy stem cell net-
work into a dangerous exponential network by the mere addition of second backwards loop.
The result can be catastrophic with explosive tumor growth. This actually happens in some
brain cancers (glioblastoma) and bone marrow cancers (acute myeloid leukemia AML and
acute lymphoblastic leukemia) where slow growing normal stem cells responsible for the re-
generating healthy cells is suddenly transformed and become explosive (see [11] for an infor-
mal account).
(a) We start with 2 stem cells (b) One extra loop mutation leads to explosive
growth
Fig. 1: A stem cells gone bad. A transformative mutation that leads to a upstream loop in
the right stem cell transforms the stem cell network into an exponential network [33, 30]. This
results in explosive growth as seen in bone marrow cancers (acute myeloid leukemia AML and
acute lymphoblastic leukemia) and brain cancers (glioblastoma).
5 Inadequacy of the standard gene-centered paradigm of how
stem cells work
The gene-centered model of cancer which dominates current scientific thinking has difficulty
explaining this phenomenon if at all because it views cancer as uncontrolled growth. This
paradigm gives no insight into how to control cancer except by finding ways to destroy cancer
cells. The therapy consists of cutting out, killing by chemicals or radiation, gene-centered
therapies and/or using the bodies own defenses (immunotherapy). Immunotherapy is the latest
hope and it appears to work for some cancers. While we all hope it will work for all cancers,
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it is still just a hope. Certainly, we have made enormous strides in treating and managing
cancer.
However, in spite of its successes, the gene-centered paradigm and the resulting research has
inherent limits in furthering our understanding of the underlying mechanisms in cancer cells.
It has no theoretical terminology to even describe the problem. Hence, the gene-centered
paradigm actually hinders finding methods that will lead to a real cure for all cancers (see
section 9).
A clear example in Mukherjee’s book Cancer the Emperor of All Maladies. In it he
writes:
In acute lymphoblastic leukemia, as in some other cancers, the overproduction of
cancer cells is combined with a mysterious arrest in the normal maturation of cells.
Lymphoid cells are thus produced in vast excess, but, unable to mature . . . [11].
In the Stem Cell Networks paradigm it is just a consequence of the structure of the network
itself, which loops back to the generating cell’s state before the cell can mature into a terminal
cell. The gene-centered view has no theoretical concept to even formulate this phenomenon let
alone to explain it1
6 The network paradigm of stem cells
In contrast my network theory of stem cells and more generally cancer networks gives an exact
explanation of these phenomena when stem cells go bad. The stem cell network paradigm
gives detailed models that can be mathematically formalized in a variety of ways, including
differential equations [10, 9, 6, 24, 2]. The networks have been used to model tumor therapies
including radiation, proton therapy. While these models use the simplest possible stem cell
network model as a starting point, in practice they use the equivalent of a stochastic stem cell
network with stochastic dedifferentiation such as the following:
1The authors Hanahan and Weinberg who wrote the influential review of the hallmarks of cancer [7] recently
updated their account to include gene regulatory networks (GRNs) [8]. However, as is shown in [31, 32] there are
inherent combinatorial limits to GRNs making them unlikely to give a realistic explanation of cancer networks of
the type described in [30, 33].
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Fig. 2: Network G1SD: A 1st-order geometric cancer with stochastic dedifferentiation.
This example is adapted from [33].
In this linear network, a cell of type A is a 1st-order, linear stem cell. It produces progenitor
cells of type B that have a stochastic dedifferentiation potential. The cell B can either dediffer-
entiate to its parent state A or differentiate into the terminal cell T . The lower the probability p
of dedifferentiation, the greater the number of terminal cells in the cell population generated by
the stem cell A. The higher the probability p the more the network approaches the topology of
a pure exponential network with explosive cell proliferation. Thus the topology of the network
is a pragmatic topology (see below) that depends on the probability distribution. The effect of
the probability distribution is shown in the following example adapted from [33]:
(a) Probability p = 0.52, gives 4%
stem cells
(b) When p = 0.7 gives 36% stem
cells
(c) Probability p = 0.9 gives 80%
stem cells
Fig. 3: Three views of stem cells under different probabilities. All three tumors are con-
trolled by a similar network as in (Fig. 2 ). It shows the growth response to changes in the
probability p. As the probability p is increased, more and more stem cells are generated due to
increasing dedifferentiation of the daughter cells to their parent stem cell. The stochastic ex-
ponential network begins to dominate as p approaches 1. Example is adapted from the classic
Till network [21] as formalized in [33].
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6.1 Stochastic linear networks formalized as differential equations
The stochastic dedifferentiation is modeled by an extra term in the differential equation that
allows a second loop from the terminal cell to occur occasionally. Where ’occasionally’ is
dependent on the magnitude of the extra term. The stochastic dedifferentiation allows the
modeling of tumors that exhibit resistance to therapy or that spontaneously reoccur after some
time of remission. The therapeutic success is dependent on the network that is actually being
modeled [10, 9, 6, 24, 2].
6.2 Pragmatic-stochastic topology of networks
The important point is that the probability distribution over a stochastic stem cell network
determines the pragmatic topology of the network. By pragmatic topology I mean the range
of network architectures between the ideal network as defined by its possible paths (the phase
space of the network) versus all the possible executions of the network given the probability
distribution. Thus we have a range of possible outcomes from a truly deterministic, linear stem
cell network (where the dedifferentiation probabilities are 0) all the way to a deterministic
exponential network (where the dedifferentiation probabilities are 1).
6.3 When non-network genes are important
There are further differences between healthy and stem cell networks that have to do with non-
networks mutations as happens, for example, when genetic mutations in genes that enable cell
migration and metastases to form.
7 Which cancer stem cells are the most dangerous?
Beyond the ever present dangerous potential of cancer stem cell networks to transform into
exponential networks (see section 4), the order of the stem cell network determines how dan-
gerous the metastatic stem cell is. A first order stem cell (controlled by a 1st order, linear
stem cell network) will only produce non-proliferative, and in this sense, harmless, terminal
cells2.
A second-order stem cell network will produce 1st order stem cells which if they metastasize
will produce unwanted cyst-like growths.
More severe is the effect of metastatic 3rd-order stem cell networks which produce 2nd-order
stem cells. Then the metastatic 2nd order cells will also produce 1st-oder stem cells leading to
faster tumor growth and possibly more metastases.
2A complication is if there is stochastic dedifferentiation in presumptive terminal cells then the probabilities
determine the effective topology of the stem cell network leading to degrees of possible non-linear growth.
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With this network understanding of higher orders of stem cells, it is clear that to treat such can-
cers that the most important cancer cell to kill first is the stem cell of the highest order.
8 Precise predictions of dynamics of proliferation
The stem cell network theory also gives precise predictions of the upper bounds of cell prolif-
eration in real tumors and cancers. As I showed in the stem cell networks paper the dynamics
and growth in an ideal context of discrete space time is related to the form classic Greek fig-
urative numbers and Platonic objects, as well as Pascal’s Triangle and the coefficients of the
Binomial Theorem. This gives the upper bounds of stem cell growth in continuous space-time
in real tumors with real cells.
9 Stem cell networks point to new methods to cure cancers
Unlike the gene-centered paradigm which views cancer as uncontrolled growth, stem cell net-
works are founded on the view that cancer like embryonic development is a highly controlled
process [24, 30, 33]. Given that stem cell networks are encoded in the genome, then a path to
cure cancer becomes possible.
1. First, we need to crack the cancer code [25, 26]. This means we need to find the trans-
lation that interrelates encoding of in silico stem cell networks with natural stem cell
networks encoded in the DNA of genomes. Once, that is achieved, we have many op-
tions by which stem cell cancers can be cured.
2. We start by searching the genome of cancer cells to find the cancer network that controls
the cancer cell’s proliferation. Once, the controlling cancer network is found there are a
number of possible options:
(a) New methods can be developed to kill all cells with the active cancer network.
A cautionary note: Killing cells with cancer networks has to be done with care,
since some cancer networks, such as networks involved in bilateral breast cancer
are most likely in the genome at birth and hence reside in every cell of the body.
Killing all cells that contain the cancer network would kill every cell in the body!
(b) Methods can be developed to edit the cancer network so as to inactivate it thereby
stopping cell proliferation3.
(c) If the cancer network is a mutated normal stem cell network, methods can be de-
veloped to edit the cancer network transforming back into its previously healthy
state. This method could be used to stop explosive cancers governed by stem cells
whose linear stem cell network has been transformed into an exponential network.
3The existence of the CRISPR biotechnology to edit genomes shows that it is in principle possible to edit cancer
networks [19, 12, 13]. This method combines search with editing.
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As the work on CRISPR by Doudna and her team indicates [19, 12, 13], future bioengineers
will, of course, find and invent many new methods to transform such cancer networks or to
carefully target and kill cells with such networks. In that sense, it is a good thing that cancer
stem cell networks are so similar to normal, healthy stem cell networks since it gives the under-
standing that is needed to precisely model and simulate such cancers. And it offers a roadmap
that may ultimately lead to a cure for such cancers.
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